Molecular Mechanisms of 6PPD and 6PPD-Q Toxicity in Neurodegenerative Diseases: A Network Toxicology and Experimental Validation Study
- 1Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410011, China
- 2Xiangya School of Medicine, Central South University, Changsha 410011, China
- 3Nanjing Institute of Environmental Sciences, Ministry of Ecology and Environment, Nanjing 210042, China
Abstract
6PPD is a widely used tire antioxidant that readily transforms into its more toxic ozonation product, 6PPD-quinone (6PPD-Q). Both compounds are emerging environmental contaminants with potential neurotoxic risks, yet their molecular mechanisms in Alzheimer's disease (AD) and Parkinson's disease (PD) remain unclear. This study integrated network toxicology, molecular docking, transcriptomic validation, and experimental models to investigate their neurotoxic effects. In silico analyses predicted significant neurotoxicity and blood-brain barrier permeability for both compounds. Target prediction and PPI network analysis identified 145/121 overlapping targets with AD/PD for 6PPD and 120/100 for 6PPD-Q. Functional enrichment analysis suggested that 6PPD-associated targets were mainly enriched in axon regeneration-, p75NTR-, and AGE-RAGE-related pathways, whereas 6PPD-Q-associated targets were enriched in MAPK cascade-, endosomal TLR signaling-, and amyloid-β formation-related pathways. Molecular docking suggested favorable binding affinities between these compounds and several core targets, including MAP2K1, EGFR, GSK3B, and CYCS. Transcriptomic validation in GEO datasets prioritized multiple hub genes. In vivo experiments showed activation of apoptosis-related signaling in the brain, while in vitro assays demonstrated ROS accumulation and neuroinflammatory activation (elevated TNF-α, IL-1β, IL-6, IFN-γ). CYCS and MAP2K1 emerged as key convergent nodes. Our findings reveal distinct yet synergistic neurotoxic mechanisms of 6PPD and 6PPD-Q in AD and PD, highlighting tire-derived pollutants as potential environmental risk factors for neurodegenerative diseases.
Related
- Network toxicology, molecular docking and in vitro validation reveal the molecular mechanisms of bisphenol A-induced MASLD
- Unraveling the therapeutic mechanisms of placenta hominis for polycystic ovary syndrome through network pharmacology, molecular docking, and experimental validation
- Revealing the toxicological effects and mechanisms of tris(1-chloro-2-propyl) phosphate exposure on osteoarthritis based on network toxicology, machine learning, and molecular docking
- Unveiling the neuroinflammatory potential of aspartame in Alzheimer’s disease: A comprehensive network toxicology and experimental validation approach
- Targeting Sirtuins in Neurodegenerative and Psychiatric Disorders: From Molecular Mechanisms to Pharmacological Modulation
BibTeX
@article{li2026molecular,
title = {{Molecular Mechanisms of 6PPD and 6PPD-Q Toxicity in Neurodegenerative Diseases: A Network Toxicology and Experimental Validation Study}},
author = {Ze Li and Yuyang Luo and Siyi Wang and Ding‐Ming Xue and Yixuan Zhang},
journal = {Toxics},
year = {2026},
month = jun,
doi = {10.3390/toxics14060504},
url = {https://doi.org/10.3390/toxics14060504},
note = {CC BY},
}
RIS
TY - JOUR
TI - Molecular Mechanisms of 6PPD and 6PPD-Q Toxicity in Neurodegenerative Diseases: A Network Toxicology and Experimental Validation Study
AU - Ze Li
AU - Yuyang Luo
AU - Siyi Wang
AU - Ding‐Ming Xue
AU - Yixuan Zhang
PY - 2026
DA - 2026/06/10
JO - Toxics
DO - 10.3390/toxics14060504
UR - https://doi.org/10.3390/toxics14060504
AB - 6PPD is a widely used tire antioxidant that readily transforms into its more toxic ozonation product, 6PPD-quinone (6PPD-Q). Both compounds are emerging environmental contaminants with potential neurotoxic risks, yet their molecular mechanisms in Alzheimer's disease (AD) and Parkinson's disease (PD) remain unclear. This study integrated network toxicology, molecular docking, transcriptomic validation, and experimental models to investigate their neurotoxic effects. In silico analyses predicted significant neurotoxicity and blood-brain barrier permeability for both compounds. Target prediction and PPI network analysis identified 145/121 overlapping targets with AD/PD for 6PPD and 120/100 for 6PPD-Q. Functional enrichment analysis suggested that 6PPD-associated targets were mainly enriched in axon regeneration-, p75NTR-, and AGE-RAGE-related pathways, whereas 6PPD-Q-associated targets were enriched in MAPK cascade-, endosomal TLR signaling-, and amyloid-β formation-related pathways. Molecular docking suggested favorable binding affinities between these compounds and several core targets, including MAP2K1, EGFR, GSK3B, and CYCS. Transcriptomic validation in GEO datasets prioritized multiple hub genes. In vivo experiments showed activation of apoptosis-related signaling in the brain, while in vitro assays demonstrated ROS accumulation and neuroinflammatory activation (elevated TNF-α, IL-1β, IL-6, IFN-γ). CYCS and MAP2K1 emerged as key convergent nodes. Our findings reveal distinct yet synergistic neurotoxic mechanisms of 6PPD and 6PPD-Q in AD and PD, highlighting tire-derived pollutants as potential environmental risk factors for neurodegenerative diseases.
SN - 2305-6304
ER -